We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




TB Blood Test Could Detect Millions of Silent Spreaders

By LabMedica International staff writers
Posted on 26 Mar 2024
Print article
Image: The blood test could identify millions of people who spread TB unknowingly (Photo courtesy of University of Southampton)
Image: The blood test could identify millions of people who spread TB unknowingly (Photo courtesy of University of Southampton)

Tuberculosis (TB) is the world's deadliest infectious disease, claiming over one million lives annually as reported by the World Health Organization. TB's transmission occurs through the air when an infected person coughs or sneezes, releasing minute droplets that can affect not just the lungs but any body part. The fight against TB's spread is significantly hampered by the current testing methods, which are not only slow but also depend on specialized equipment and laboratory settings. Consequently, nearly three million TB cases went undetected last year, predominantly in developing nations, with a third of infected individuals remaining undiagnosed and, thus, contagious. In a significant development, scientists have advanced towards developing a blood test capable of detecting millions of people who are unknowingly transmitting TB.

In a pioneering study conducted by the University of Southampton (Southampton, UK), researchers have identified a specific group of biological markers present in high levels in individuals who are infectious. This discovery holds the promise of a simple diagnostic test capable of identifying and halting the spread of the disease, which affects an estimated 10 million people each year. Collaborating with international experts, these scientists performed the most detailed examination of blood markers associated with this bacterial infection. Utilizing an innovative approach, they identified six proteins that show a high degree of accuracy in identifying individuals with active TB.

The research team analyzed blood proteins from people with active TB located in Africa and South America, comparing these biomarkers against those found in healthy individuals and others with lung infections. They discovered 118 proteins that varied markedly between these groups. From these, they narrowed down to six proteins which they found could be used to effectively differentiate individuals with contagious TB from those who are healthy or have other lung ailments. This breakthrough finding paves the way for the development of a TB test which could be as simple as the lateral flow tests widely used during the recent pandemic.

“In our study, we combined a new measurement technique with deep mathematical analysis to identify these six new markers of TB disease,” said Dr. Hannah Schiff, a respiratory expert at Southampton. “It could lead to a transformative alternative to diagnosing the condition – a simple test that detects proteins in the bloodstream whose levels differ between people with TB, healthy individuals, and those suffering from other respiratory illnesses.”

Related Links:
University of Southampton

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.